SANIPROJECT has signed agreements for the commercialization and distribution of Medicines under Special Situations with Pharmaceutical Laboratories, Research institutions and developing pharmaceutical companies that allow access to the supply of a large number of references of pharmaceutical products.
These Technical and Commercial agreements allow Pharmaceutical Laboratories to commercialize their products internationally even before the issue of the Marketing Authorization by the Health Authorities in each country:
- Early Access Programs.
- Compassionate Use Programs
- Name Patient Programs
- Clinical Trials.
Always accomplishing with the pharmaceutical legislation and ethical standards established in each country, these agreements allow health professionals and patients to know and have early access to the pharmaceutical products prior to their commercial launch.
The agreements that SANIPROJECT has reached with pharmaceutical laboratorios, research institutions and companies that develop new drugs ensure:
- Ethical, responsible and reliable management of UNLICENSED DRUGS.
- Establishment of Quality and Safety assurance policies for the pharmaceutical products.
- Establishment of Pharmacovigilance Responsibility policies.
- Legal and regulatory experience and local know-how in each country.
- Assistance 24 hours a day, 7 days a week.
- Native professional teams in each country (knowledge of local problems).
